TURKEL CATHERINE C. 4
4 · Lexaria Bioscience Corp. · Filed Sep 6, 2022
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Director
Transactions
- Award
Stock Options
2022-09-02+3,400→ 3,400 totalExercise: $3.04From: 2022-09-02Exp: 2027-09-02→ Common Shares (3,400 underlying)